213 related articles for article (PubMed ID: 38618716)
41. Hydrogen sulfide inhibits Ca
Papu John AS; Kundu S; Pushpakumar S; Amin M; Tyagi SC; Sen U
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E269-E283. PubMed ID: 31039005
[TBL] [Abstract][Full Text] [Related]
42. The role of succinate and ROS in reperfusion injury - A critical appraisal.
Andrienko TN; Pasdois P; Pereira GC; Ovens MJ; Halestrap AP
J Mol Cell Cardiol; 2017 Sep; 110():1-14. PubMed ID: 28689004
[TBL] [Abstract][Full Text] [Related]
43. CaMKII determines mitochondrial stress responses in heart.
Joiner ML; Koval OM; Li J; He BJ; Allamargot C; Gao Z; Luczak ED; Hall DD; Fink BD; Chen B; Yang J; Moore SA; Scholz TD; Strack S; Mohler PJ; Sivitz WI; Song LS; Anderson ME
Nature; 2012 Nov; 491(7423):269-73. PubMed ID: 23051746
[TBL] [Abstract][Full Text] [Related]
44. Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+.
Sedlic F; Sepac A; Pravdic D; Camara AK; Bienengraeber M; Brzezinska AK; Wakatsuki T; Bosnjak ZJ
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C506-15. PubMed ID: 20519447
[TBL] [Abstract][Full Text] [Related]
45. [Hydrogen sulfide inhibits Ca(2+)-induced mitochondrial permeability transition pore opening in adult and old rat heart].
Strutyns'ka NA; Semenykhina OM; Chorna SV; Vavilova HL; Sahach VF
Fiziol Zh (1994); 2011; 57(6):3-14. PubMed ID: 22420153
[TBL] [Abstract][Full Text] [Related]
46. A novel class of cardioprotective small-molecule PTP inhibitors.
Antonucci S; Di Sante M; Sileikyte J; Deveraux J; Bauer T; Bround MJ; Menabò R; Paillard M; Alanova P; Carraro M; Ovize M; Molkentin JD; Cohen M; Forte MA; Bernardi P; Di Lisa F; Murphy E
Pharmacol Res; 2020 Jan; 151():104548. PubMed ID: 31759087
[TBL] [Abstract][Full Text] [Related]
47. Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Li X; Jia P; Huang Z; Liu S; Miao J; Guo Y; Wu N; Jia D
Drug Des Devel Ther; 2019; 13():2331-2342. PubMed ID: 31371925
[TBL] [Abstract][Full Text] [Related]
48. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
49. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
[TBL] [Abstract][Full Text] [Related]
50. The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation.
Martin LJ; Adams NA; Pan Y; Price A; Wong M
J Neurosci; 2011 Jan; 31(1):359-70. PubMed ID: 21209222
[TBL] [Abstract][Full Text] [Related]
51. Cardiac ischemia/reperfusion stress reduces inner mitochondrial membrane protein (mitofilin) levels during early reperfusion.
Tombo N; Imam Aliagan AD; Feng Y; Singh H; Bopassa JC
Free Radic Biol Med; 2020 Oct; 158():181-194. PubMed ID: 32726689
[TBL] [Abstract][Full Text] [Related]
52. Cyclophilin D Regulates Oxidative Stress and Apoptosis
Hong K; Yang Q; Liu G; Qiu H; Yu B
Curr Mol Med; 2023; 23(9):971-980. PubMed ID: 36089783
[TBL] [Abstract][Full Text] [Related]
53. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening.
Xu T; Ding W; Ao X; Chu X; Wan Q; Wang Y; Xiao D; Yu W; Li M; Yu F; Wang J
Redox Biol; 2019 Jan; 20():414-426. PubMed ID: 30415165
[TBL] [Abstract][Full Text] [Related]
54. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
[TBL] [Abstract][Full Text] [Related]
55. Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore.
Quinsay MN; Thomas RL; Lee Y; Gustafsson AB
Autophagy; 2010 Oct; 6(7):855-62. PubMed ID: 20668412
[TBL] [Abstract][Full Text] [Related]
56. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury.
Morciano G; Giorgi C; Bonora M; Punzetti S; Pavasini R; Wieckowski MR; Campo G; Pinton P
J Mol Cell Cardiol; 2015 Jan; 78():142-53. PubMed ID: 25172387
[TBL] [Abstract][Full Text] [Related]
57. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
[TBL] [Abstract][Full Text] [Related]
58. Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels.
Feng Y; Madungwe NB; Imam Aliagan AD; Tombo N; Bopassa JC
Biochem Biophys Res Commun; 2019 Dec; 520(3):606-611. PubMed ID: 31623831
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
Paradies G; Paradies V; Ruggiero FM; Petrosillo G
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
[TBL] [Abstract][Full Text] [Related]
60. [Mitochondria permeability transition as a target for ischemic preconditioning].
Hoshovs'ka IuV; Shymans'ka TV; Rudyk OV; Korkach IuP; Sahach VF
Fiziol Zh (1994); 2011; 57(4):34-45. PubMed ID: 22164407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
